Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis

 

Training Set

Validation Set

P T-V

 

MCD

FSGS

P

MCD

FSGS

P

MCD

FSGS

No. of subjects

10

11

 

14

14

   

Age (years)

39.5 (28.0 –68.0)

57.0 (31.0 –71.0)

0.57

55.5 (30.0 –72.0)

54.5 (36.0 –59.0)

0.45

0.32

0.85

Female/male ratio

3/7

5/6

0.47

6/8

2/12

0.09

0.52

0.08

Body mass index (kg/m2)

27.3 (21.9 –33.8)

25.5 (24.0 –26.6)

0.68

29.4 (24.2 –30.6)

26.3 (25.1 –28.4)

0.63

0.76

0.41

Body surface area

1.7 (1.7 –1. 9)

1.8 (1.6 –1.8)

0.83

1.8 (1.6 –1.9)

1.9 (1.8 –2.0)

0.35

0.52

0.11

Serum glucose (mg/dl)

91 (81–101)

88 (83–97)

0.89

84 (81–94)

94 (87–97)

0.19

0.44

0.67

Serum protein (g/dl)

4.4 (3.7 –4.7)

5.0 (4.1 –6.2)

0.09

4.7 (4.1 –4.9)

6.1 (4.5 –6.3)

0.05

0.29

0.56

Serum creatinine (mg/dl)

0.9 (0.8 –1.0)

1.2 (0.9 –1.2)

0.12

0.9 (0.8 –1.3)

1.3 (0.9 –1.8)

0.24

0.64

0.62

Proteinuria (g/24 h)

10.6 (2.3 –12.2)

3.5 (2.5 –7.4)

0.29

9.7 (5.9 –15.0)

3.4 (1.7 –4.5)

0.004

0.52

0.64

  1. Data are shown as median (interquartile range)
  2. Differences between groups were tested using the non-parametric Kruskall Wallis test. P T-V shows P value between training and validation set. P < 0.05 was considered significant